![Terumo Symposium Terumo Symposium]() | Is there still a place for innovation in intra-arterial therapies in HCC? Chairman: Prof. T. de Baère Overall objectives
Look at the latest experience of intra-arterial therapies in HCC Discuss latest TACE practice recommendations Share the clinical value of LifePearl use through the results from a 580 HCC patients pooled analysis Discuss curative intent treatment pathways in HCC from the digestive oncologist‘s and surgeon‘s perspective
| Prof. Thierry De Baère Chairman Institut Gustave Roussy, France |
|
|
| Prof. Philippe Pereira SLK - Kliniken Heilbronn GmbH, Germany |
|
|
| Dr. Gontran Verset Erasme Hospital, Belgium |
|
|
| Dr. Desislava Germanova Erasme Hospital, Belgium |
|
| ![Watch the session Watch the session]() |
|
|
|
Further information about our sessions during ECIO 2023 | ![Learn more Learn more]() |
|
|